Our Team

Vast experience
and great access to deal flow

Christian Angermayer
Christian Angermayer
Founder

Strategy and investor relations

  • Serial entrepreneur and investor
  • Co-founder, Ribopharma (RNAi translation, today Alnylam, $10bn market cap)
  • Raised $1.5bn+ over the last 20 years for portfolio companies
  • Invests across the entire lifecycle of a company and has been involved in more than 40 successful IPOs and M&As
Florian Brand
Florian Brand
Co-Founder and Chief Executive Officer

Executing drug development and operations

  • Interim CEO, Perception Neuroscience
  • Former Co-founder and MD, Springlane
  • Prior experience with Rocket Internet, Allianz, Tanzanian German Program to Support Health
  • Background: Economics and management
Matthias Luz, MD
Matthias Luz, MD
Chief Medical Officer

Developing clinical strategy for lead compounds

  • 26+ years of experience in various leadership roles in the biopharmaceutical industry
  • Broad experience in various disease areas (e.g. CNS and cardiovascular)
  • Background: Board-certified anesthesiologist and researcher in Heidelberg and Harvard
Srinivas Rao, MD, PhD
Srinivas Rao, MD, PhD
Chief Scientific Officer

Advance the science into clinical evaluation

  • 20+ years of experience in various CSO and CMO leadership roles
  • Deep experience in IT
  • Background: MS in computer engineering and MD and PhD in Neuropharmacology (Yale-trained)
Greg Bates
Greg Bates
Lead, Regulatory Affairs

Successful product approval

  • 32 years in international pharmaceutical industry
  • Extensive experience in international regulatory affairs encompassing drug regulation, biologics and live biotherapeutic products
  • Background: Veterinary
Danny Talati
Danny Talati
Lead, Business Development

Compound sourcing and evaluating

  • 6+ years of neuroscience and neurology medical experience, Eli Lilly
  • Prior experience in biotech business development and consulting
  • Background: Pharmacy and management
Roman Dahl
Roman Dahl
Lead, Operations & Data

Innovation through flawless execution and cutting-edge data & technology

  • 8 years of operations experience across product and commercial strategy (McKinsey, BCG, KPMG, Siemens)
  • Leading experience in combining healthcare, data and (AI) technology (Google, DeepMind)
  • Background: Management studies in the UK, France, Germany and Argentina
Aaron Weaver
Aaron Weaver
Senior Legal Counsel

Legal and financial expertise

  • Ex-magic circle firm lawyer and ex-bulge bracket investment banker
  • Extensive experience across most asset classes
  • Industry experience in media and China tech.
Simon Seibold
Simon Seibold
Assiociate

Investments and business development

  • Founder of AI-based application with neural network approach
  • Experience in venture capital with focus on digital health and therapeutics
  • Background: Psychology, medicine and management
Ana Zarzosa
Ana Zarzosa
Team and Resarch assistant

Supporting smooth communication and a high-performance team environment

  • 10+ years of experience in Yoga and Mindfulness
  • 7 years of Scientific Research in Life Sciences (Dr.rer.nat)
  • Prior experience in team management, company organization and healthcare industry
  • Background: Nutrition, genetics, molecular & cell biology
Philipp Schreiber
Philipp Schreiber
Associate

Drug discovery and compound sourcing

  • Portfolio development, Apeiron Investment Group
  • Experience in M&A transactions, venture capital and strategic management
  • Background: Management, entrepreneurship and business law
Allan Malievsky
Allan Malievsky
Associate

Communications and Business Development

  • Led membership development at DC-based nonprofit working on advanced illness care issues and Medicare payment reform
  • Experience in fundraising and communications for thought leaders
  • Background: Economics, international affairs, and healthcare policy
Ali Mahomed
Ali Mahomed
Analyst

Operationally growing portfolio companies

  • Previously at COMPASS Pathways
  • Internship experience in mergers & acquisitions and private equity
  • Background: Statistics and finance